APPLICATION
ANDA074782
TYPE
ANDA
ORIGINAL APPROVAL
1998-07-06
LATEST ACTION
2006-03-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
IBUPROFENDiscontinued
IBUPROFEN 200MG · CAPSULE · ORAL
Approval history
2006-03-22Labeling · Supplement 4AP
2000-10-27Manufacturing (CMC) · Supplement 3AP
1999-12-01Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.